glp 1 hepatic steatosis Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) How Far beyond Diabetes Can

GliSODin was shown to protect against cellular oxidative stress damage in a dramatic human model

The composite endpoint included the need for retinal photocoagulation, treatment with intravitreal agents, vitreous hemorrhage, or diabetes-related blindness

We now know that 1 in 350 males indeed cannot synthesize carnitine

Major biopharmaceutical companies, including Novo Nordisk, Veru Inc., Viking Therapeutics, Inc., Terns Pharmaceuticals, Eccogene, AstraZeneca, and others, are driving innovation in the GLP-1 agonists space through robust pipelines, strategic collaborations, and the development of next-generation treatments targeting diabetes, obesity, and related metabolic disorders

While it is not specifically developed as a hair regrowth treatment, it may help support a healthy scalp environment, which plays an important role in hair follicle function